World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
81
Citations
17642
World Ranking
1593
National Ranking
61

Medicine

D-Index
81
Citations
17702
World Ranking
16837
National Ranking
635

Pieter C. Limburg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pieter C. Limburg sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 281 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pieter C. Limburg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pieter C. Limburg sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Pieter C. Limburg is affiliated with the University of Groningen in the Netherlands. The academic profile of Limburg reflects a researcher actively engaged in scholarly work associated with this institution.

There is no publicly available information about Limburg's recent papers, co-authors, publication venues, or book publications. Specific research fields, subfields, and topical areas related to Limburg's work have also not been documented.

Details about awards or honors received by Limburg, including years and citations, are not recorded in accessible data sources.

As an active researcher, Limburg's contributions may be reflected in ongoing work at the University of Groningen, although further details of published studies or collaborations are not currently found in the presented data.

Best Publications

  • Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.

    E. J. Ter Borg;G. Horst;E. J. Hummel;P. C. Limburg

  • Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.

    M. M. Boomsma;C. A. Stegeman;M. J. Van Der Leij;W. Oost

  • Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro.

    Mwn Nijsten;P Olinga;Ege de Vries

  • Prevention of relapses in systemic lupus erythematosus.

    H. Bootsma;P. Spronk;G. de Boer;P. Limburg

  • The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes.

    H.J. Moshage;H.M.J. Roelofs;J.F. van Pelt;B.P.C. Hazenberg

  • Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants

    M. A. Van Leeuwen;D. M. F. M. Van Der Heijde;M. H. Van Rijswijk;P. M. Houtman

  • Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study

    M. M. Van Gameren;P. H. B. Willemse;N. H. Mulder;P. C. Limburg

  • Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process.

    A. H. L. Mulder;P. Heeringa;E. Brouwer;P. C. Limburg

  • ASSOCIATION OF AUTOANTIBODIES TO MYELOPEROXIDASE WITH DIFFERENT FORMS OF VASCULITIS

    J. W. Cohen Tervaert;R. Goldschmeding;J. D. Elema;P. C. Limburg

  • Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis: towards development of a decision support system

    M. A. Van Leeuwen;M. H. Van Rijswijk;W.J. Sluiter;P. L. C. M. Van Riel

  • PREVALENCE AND CHARACTERIZATION OF NEUTROPHIL CYTOPLASMIC ANTIBODIES IN AUTOIMMUNE LIVER-DISEASES

    A. H. L. Mulder;G. Horst;E. B. Haagsma;P. C. Limburg

  • Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients.

    P.C. Limburg;E. Hummel-Tappel;H.J.G.H. Oosterhuis

  • The Acute-Phase Response in Relation to Radiographic Progression in Early Rheumatoid Arthritis: A Prospective Study During the First Three Years of the Disease

    M. A. van Leeuwen;M. H. van Rijswijk;D. M. F. M. van der Heijde;G. J. Te Meerman

  • EFFECTS OF FISH OIL SUPPLEMENTATION IN RHEUMATOID-ARTHRITIS

    H. van der Tempel;J. E. Tulleken;P. C. Limburg;F. A. J. Muskiet

  • Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission.

    Wayel H. Abdulahad;Coen A. Stegeman;Pieter C. Limburg;Cees G. M. Kallenberg

  • Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders.

    E. Brouwer;J. W. Cohen Tervaert;G. Horst;M. G. Huitema

  • Anti-acetylcholine receptor antibodies in myasthenia gravis: Part 2. Clinical and serological follow-up of individual patients

    H.J.G.H. Oosterhuis;P.C. Limburg;E. Hummel-Tappel

  • Differential effects of NF-kappa B and p38 MAPK inhibitors and combinations thereof on TNF-alpha- and IL-1 beta-induced proinflammatory status of endothelial cells in vitro

    Joanna M. Kułdo;Johanna Westra;Sigridur A. Ásgeirsdóttir;Robbert J. Kok

  • Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.

    Wayel H Abdulahad;Coen A Stegeman;Ymke M van der Geld;Berber Doornbos-van der Meer

  • Levels of soluble VCAM‐1, soluble ICAM‐1, and soluble E‐selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study

    P. E. Spronk;H. Bootsma;M. G. Huitema;P. C. Limburg

  • C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study.

    Ej Terborg;G Horst;Pieter Limburg;Mh Vanrijswijk

Frequent Co-Authors

Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
Coen A. Stegeman
Coen A. Stegeman University Medical Center Groningen
Marc Bijl
Marc Bijl University Medical Center Groningen
Peter Heeringa
Peter Heeringa University Medical Center Groningen
Jan H. Kleibeuker
Jan H. Kleibeuker University Medical Center Groningen
Hendrika Bootsma
Hendrika Bootsma University Medical Center Groningen
Pieter J. Hoekstra
Pieter J. Hoekstra University Medical Center Groningen
Jan Willem Cohen Tervaert
Jan Willem Cohen Tervaert University of Alberta
Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
Elisabeth G.E. de Vries
Elisabeth G.E. de Vries University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many students consider nursing pathways, which often provide quicker routes into the healthcare field. Programs like accelerated fnp help registered nurses advance to become family nurse practitioners rapidly, combining clinical expertise with immunological knowledge.

For individuals without a nursing background, online absn programs for non nurses offer a streamlined path to enter nursing. These programs allow non-nurses to earn a Bachelor of Science in Nursing (BSN) efficiently, making immunology-related nursing roles more accessible.

Admission can be competitive, but there are absn programs with high acceptance rates designed to accommodate more applicants, helping students start their careers sooner. Similarly, those seeking quicker entry-level credentials might explore accredited lpn programs easy to get into, which provide foundational clinical skills applicable in immunology-focused settings.

Each of these degree pathways supports a strong foundation in healthcare, complementing immunology studies and expanding career prospects.

Best Scientists Citing Pieter C. Limburg

Trending Scientists

Recently Published Articles